Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Does Blood Glucose or Obesity Alter Gut Barrier Function and Metabolic Endotoxemia?
FY 2021-22
Summary
Obesity, type 2 diabetes (T2D), and non-alcoholic fatty liver disease are interlinked diseases that have high health and economic burdens. Most research associates intestinal bacteria to T2D and fatty liver disease by describing changes in the names of bacterial during obesogenic diets. An important goal is to identify bacterial processes and molecules that cause effects on host metabolism and can be manipulated to combat metabolic disease and T2D. Postbiotics are bacterial components that come from living or dead bacteria. Postbiotics such as lipopolysaccharide (LPS) can cause immune responses such as inflammation, and increased inflammation can promote metabolic dysfunction. ;Metabolic endotoxemia describes a low-level increase in blood LPS. We recently discovered that the type of LPS determines a positive or negative effect on host metabolism. However, it is not known what features of metabolic disease influence the type of LPS.Changes in the gut microbiome or gut barrier function may alter the balance or type of circulating LPS. We hypothesize that the level of blood glucose and level of body fat dictate whether LPS is detrimental or beneficial during metabolic endotoxemia. We will use control, hyperglycemic (Akita), and normoglycemic Akita (treated with chronic insulin) mice to determine if different levels of blood glucose influence the type and activity of LPS in the gut, portal, and systemic blood circulation in lean mice. Similarly, we will compare lean mice to obese mice to determine whether obesity at different ages influences metabolic endotoxemia. This research may lead to understanding which factor in metabolic disease influences a source of inflammation that contributes to aggravating metabolic disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466952
Name
Bhatwa Arshpreet
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Does Blood Glucose or Obesity Alter Gut Barrier Function and Metabolic Endotoxemia?
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biochemistry; Blood Glucose; Diabetes; Endotoxemia; Immunology; Immunometabolism; Inflammation; Lipopolysaccharide; Metabolism; Obesity
Abstract
Obesity, type 2 diabetes (T2D), and non-alcoholic fatty liver disease are interlinked diseases that have high health and economic burdens. Most research associates intestinal bacteria to T2D and fatty liver disease by describing changes in the names of bacterial during obesogenic diets. An important goal is to identify bacterial processes and molecules that cause effects on host metabolism and can be manipulated to combat metabolic disease and T2D. Postbiotics are bacterial components that come from living or dead bacteria. Postbiotics such as lipopolysaccharide (LPS) can cause immune responses such as inflammation, and increased inflammation can promote metabolic dysfunction. ;Metabolic endotoxemia describes a low-level increase in blood LPS. We recently discovered that the type of LPS determines a positive or negative effect on host metabolism. However, it is not known what features of metabolic disease influence the type of LPS.Changes in the gut microbiome or gut barrier function may alter the balance or type of circulating LPS. We hypothesize that the level of blood glucose and level of body fat dictate whether LPS is detrimental or beneficial during metabolic endotoxemia. We will use control, hyperglycemic (Akita), and normoglycemic Akita (treated with chronic insulin) mice to determine if different levels of blood glucose influence the type and activity of LPS in the gut, portal, and systemic blood circulation in lean mice. Similarly, we will compare lean mice to obese mice to determine whether obesity at different ages influences metabolic endotoxemia. This research may lead to understanding which factor in metabolic disease influences a source of inflammation that contributes to aggravating metabolic disease.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bhatwa, Arshpreet
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~